CRE Isolate Submission and Laboratory Testing - Minnesota Dept. of Health

CRE Isolate Submission and Laboratory Testing

The term CRE refers to carbapenem-resistant Enterobacteriaceae. Some CRE produce enzymes called carbapenemases that break apart carbapenems; these are referred to as carbapenemase-producing CRE (CP-CRE). Currently, the most common type of carbapenemase in the United States is the Klebsiella pneumoniae carbapenemase (KPC). In 2010, carbapenemases known as metallo-beta-lactamases (MBL) were first detected in the U.S. These include the New Delhi MBL (NDM),  Imipenemase (IMP), and Verona integron-encoded MBL (VIM). Another important emerging carbapenemase is OXA-48. The genes encoding carbapenemases are often located on plasmids that are easily spread between organisms.

It is important for laboratories to implement the current Clinical and Laboratory Standards Institute (CLSI) breakpoints for Enterobacteriaceae and carbapenems in order to appropriately identify CRE.

On this page:
Criteria for Submission of Isolates
Appropriate Specimen Types
Specimen submission forms
Shipping to MDH-PHL
Laboratory Testing for Carbapenemase-Producing CRE
Outbreak and surveillance testing
Other CRE laboratory information
Questions

Criteria for submission of isolates

  • Klebsiella spp., Enterobacter spp., Escherichia coli, and Citrobacter spp. isolates meeting the following CLSI breakpoints (current CLSI standard) should be reported and an isolate submitted to the MDH-PHL:
Antibiotic MIC (µg/mL)
Ertapenem ≥2, R
Imipenem ≥4, R
Meropenem ≥4, R
Doripenem ≥4, R

  • Isolates found to carry a carbapenemase enzyme (such as KPC) as demonstrated by testing methods such as polymerase chain reaction (PCR), modified Hodge test, etc.
  • Other Enterobacteriaciae spp. resistant to any carbapenem antibiotic can also be submitted to the MDH-PHL for further characterization

Appropriate specimen types

  • A pure, low passage CRE isolate is preferred as some carbapenem resistance mechanisms are plasmid-based and can be lost with multiple subcultures.
  • Submit isolate on a non-inhibitory, non-selective agar plate or slant (e.g. Sheep blood agar, Tryptic soy agar, etc.)

Specimen submission forms

MDH-PHL requests the following documentation to be included with each CRE isolate submission:

  • Clinical Testing and Submission Form (required):
  • Antimicrobial Susceptibility Testing (AST) Report Printout (required):
    • Submit the raw data MIC profile obtained from your AST Instrument (i.e. Vitek2, Microscan, Phoenix)
    • Note: for manual Microscan users, a hand-written AST report is acceptable
  • CRE and CRPA Isolate - Supplemental Submission Form (PDF)
    (optional - print and fill out manually):
    • This form was created to allow MLS laboratories to record results for any CRE testing performed prior to isolate submission.
    • Results could include: Modified Hodge Test Results, Carbapenem E-test Results, Carbapenem Disk Diffusion Results, Select Antimicrobial Agent Results, and/or Results from Other Tests Performed (i.e. Carba NP, PCR)

Shipping to MDH-PHL

  • Ship specimens to MDH-PHL by an overnight delivery service or local courier.
    Note: It is the responsibility of the submitting laboratory to determine the appropriate packaging and shipping for patient specimens and culture isolates. See U.S. Department of Transportation Regulations for more information. Attention: Non-MDH link
  • Isolates can be shipped at either room temperature or with refrigeration.
  • Ship to:
    Minnesota Department of Health
    Public Health Laboratory
    Attn: Biological Accessioning
    601 Robert St. N
    St. Paul, Minnesota 55155-2531

Laboratory Testing for Carbapenemase-Producing CRE

MDH CRE outbreak and surveillance testing

Other CRE laboratory information

  • Minnesota Laboratory System: Disease Specific Information: Carbapenem Resistant Enterobacteriaceae (CRE)
    Minnesota Laboratory System (MLS) updates on CRE/KPC for Minnesota laboratories including links to other MDH and CDC Laboratory Specific CRE Information:
    • MDH links include: handouts for MDH CRE webinars, links for health professionals, and MLS laboratory updates
    • CDC links include: CDC protocols for the Multiplex Real-Time KPC and NDM polymerase chain reaction, the Modified Hodge Test, and Protocol for the Recovery of Carbapenem-Resistant Enterobacteriaceae from Rectal Swabs

Questions?

MDH-PHL Special Microbiology Laboratory is available during regular business hours for consultation on CRE testing and result interpretation (651-201-5073).

Updated Monday, October 03, 2016 at 11:32AM